Tripodal Half-Sandwich Rhodium and Iridium Complexes Containing Sulfonate and Pyridinyl Entities as Antitumor Agents

Andrew R. Burgoyne, Catherine H. Kaschula, M. Iqbal Parker, Gregory S. Smith

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Abstract

In light of the widely used platinum anticancer drugs showing high toxicity and poor selectivity, the quest to develop new anticancer agents is increasing. This study investigated the synthesis of mononuclear and trinuclear RhIII and IrIII sulfonate-containing pyridinyl complexes that have been fully characterized using NMR and IR spectroscopy, HR-ESI-mass spectrometry and elemental analysis. The cytotoxicities of all sulfonated pyridinyl compounds were investigated against a WHCO1 oesophageal cancer cell line and the metal complexes showed moderate activity, while the uncomplexed ligands were inactive. Several of the trinuclear complexes are of comparable activity to that of the clinical cancer drug cisplatin. 1H NMR model studies demonstrated the in vitro DNA binding ability of the most active complex.

Original languageEnglish
Pages (from-to)5379-5386
Number of pages8
JournalEuropean Journal of Inorganic Chemistry
Volume2017
Issue number45
DOIs
StatePublished - Dec 8 2017
Externally publishedYes

Funding

Financial support from the University of Cape Town, the National Research Foundation (NRF) of South Africa (Grant no.: 90500) and the Cancer Association of South Africa is gratefully acknowledged.

FundersFunder number
National Research Foundation
National Research Foundation90500
Cancer Association of South Africa
University of Cape Town

    Keywords

    • Antitumor agents
    • Bioinorganic chemistry
    • DNA binding
    • Half-sandwich complexes
    • Sulfonates

    Fingerprint

    Dive into the research topics of 'Tripodal Half-Sandwich Rhodium and Iridium Complexes Containing Sulfonate and Pyridinyl Entities as Antitumor Agents'. Together they form a unique fingerprint.

    Cite this